Table 1.

Number and Prevalence of Patients Screening Positive for HCV Antibodies (July 31, 2017, and June 30, 2018) and Subsequent Advancement Through the HCV Care Continuum Until June 30, 2019

	Screened HCV Antibody Positive	Received Confirmatory Testing		HCV Viral RNA Positive		Referred to Specialist		Received Specialist Evaluation		Prescribed Treatment
Characteristicc	No.	No.	%	No.	%a	No.	%b	No.	%b	No.	%b
Total	2450	2016	82.3	1081	53.6	915	84.6	540	50.0	299	27.7
Race & ethnicity
Hispanic	690	594	86.1	249	41.9	213	85.5	141	56.6	79	31.7
NH black	1021	829	81.2	502	60.6	424	84.5	250	49.8	139	27.7
NH white	602	492	81.7	296	60.2	248	83.8	130	43.9	73	24.7
Other	137	101	73.7	34	33.7	30	88.2	19	55.9	8	23.5
Gender
Male	1495	1214	81.2	746	61.4	619	83.0	350	46.9	202	27.1
Female	954	802	84.1	335	41.8	296	88.4	190	56.7	97	29.0
Birth cohort
1945–1965	1642	1347	82.0	769	57.1	659	85.7	391	50.8	212	27.6
Other	808	669	82.8	312	46.6	256	82.1	149	47.8	87	27.9
Homelessness
Homeless	155	135	87.1	83	61.5	76	91.6	40	48.2	29	34.9
Not homeless	2295	1881	82.0	998	53.1	839	84.1	500	50.1	270	27.1
History of substance use
Yes	820	676	82.4	441	65.2	365	82.8	195	44.2	104	23.6
No	1400	1141	81.5	545	47.8	472	86.6	294	53.9	170	31.2
Sexual activity
Risk activity	23	20	87.0	15	75.0	13	86.7	9	60.0	4	26.7
No risk activity	2197	1797	81.8	971	54.0	824	84.9	480	49.4	270	27.8
Alcohol
Alcohol use	513	427	83.2	273	63.9	235	86.1	138	50.5	73	26.7
No alcohol use	1707	1390	81.4	713	51.3	602	84.4	351	49.2	201	28.2

Abbreviations: EMR, electronic medical record; HCV, hepatitis C virus; NH, non-Hispanic.

^aPercentage of all individuals receiving quantitative RNA testing.

^bPercentage of all individuals testing positive for HCV RNA.

^cInformation on some risk factors was not recorded in EMRs for some patients.